GOAL 3
PrivateLast Round
Grant
Mar 9, 2026
Total Funding Raised
$2.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GOAL 3 is a medtech company that develops patient monitoring systems and clinical support platforms designed for resource-limited healthcare settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GOAL 3 Comparables
Compare GOAL 3 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neopenda | 85% | |
| Sibel Health | 77% | |
| BEMPU Health | 76% |
GOAL 3 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 9, 2026 | ||||
| Grant | Jan 28, 2026 | ||||
| Grant | Sep 22, 2025 | ||||
| Grant | Sep 30, 2024 | ||||
| Seed | May 1, 2022 | ||||
Pre Seed | Feb 1, 2021 |
Key People
Founding team and executive leadership
GOAL 3 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIT Solve | Grant |
| HealthTech Hub Africa | Accelerator |
| Philips Foundation Impact Investments B.V. | Seed |
| Johnson & Johnson Foundation | Grant |
| Eurostars SME programme | Grant |
| develoPPP Ventures | Grant |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 357% MoM, reaching 2.3K.
- Mar 9, 2026
$110K grant received from develoPPP Ventures.
GOAL 3 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GOAL 3's valuation, stock price, and market status.
Is GOAL 3 a public or private company?
GOAL 3 is a private company.
What is the current stock price of GOAL 3?
GOAL 3 is a private company with no public stock price. No recent secondary market data is available.
How much is GOAL 3 worth (valuation)?
Valuation information for GOAL 3 is not publicly available.
Can I buy GOAL 3 stock?
GOAL 3 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GOAL 3's last funding round?
GOAL 3's most recent funding round was Grant on March 9, 2026.
Who are the main investors in GOAL 3?
Key investors in GOAL 3 include MIT Solve, HealthTech Hub Africa, Philips Foundation Impact Investments B.V., Johnson & Johnson Foundation, Eurostars SME programme.
Will GOAL 3 IPO soon?
No public IPO plans have been announced for GOAL 3.
How can I track GOAL 3 secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GOAL 3's secondary market activity and sign up for updates.